Remission in Subjects With Crohn's Disease, 1 Year Phase
Completed · Phase 3 · Has a placebo group
Conditions studied: Crohn's Disease
In brief
The objectives were: (1) To demonstrate the efficacy of adalimumab in the maintenance of clinical remission up to 56 weeks in participants with Crohn's disease who participated in NCT00055523; (2) To delineate the safety of adalimumab when administered to participants with Crohn's disease up to 56 weeks.
Key facts
- Study ID
- NCT00055497
- Run by
- Abbott
- People needed
- 276
- Starts
- 2002-08-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2011-04-11
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Gastroenterology Associates of the East Bay — Berkeley, California, United States
- Long Beach Gastroenterology Assoc. — Long Beach, California, United States
- Sharp Rees-Stealy Medical Group — San Diego, California, United States
- Gastroenterology Assoc. of Fairfield Co. — Bridgeport, Connecticut, United States
- Cleveland Clinic Florida — Weston, Florida, United States
- Wake Research Associates — Weston, Florida, United States
- Shafran Gastroenterology Center — Winter Park, Florida, United States
- Atlanta Gastroenterology Assoc. — Atlanta, Georgia, United States
- Southeastern Digestive & Liver Disease — Savannah, Georgia, United States
- Northwest Gastroenterologists, S.C. — Arlington Heights, Illinois, United States
- University of Chicago — Chicago, Illinois, United States
- Drug Research Services, Inc. — Metairie, Louisiana, United States
- LSU School of Medicine — New Orleans, Louisiana, United States
- Digestive Disorders Associates — Annapolis, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Clinical Pharmacology Study Group — Worchester, Massachusetts, United States
- Mayo Clinic and Mayo Foundation — Rochester, Minnesota, United States
- Gastroenterology and Hepatology — Kansas City, Missouri, United States
- Glenn Gordon, MD — Mexico, Missouri, United States
- Deaconess Billings Clinic Research Division — Billings, Montana, United States
- Gastroenterology Specialties, P.C. — Lincoln, Nebraska, United States
- Long Island Clinical Research Associates — Great Neck, New York, United States
- NY Center for Clinical Research — Lake Success, New York, United States
- New York Presbyterian Hospital — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.